Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases (ThalaCoV)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04526405 |
Recruitment Status :
Completed
First Posted : August 25, 2020
Last Update Posted : November 9, 2020
|
Sponsor:
University of Milano Bicocca
Information provided by (Responsible Party):
University of Milano Bicocca
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | November 3, 2020 |
Actual Study Completion Date : | November 3, 2020 |
Publications of Results:
Valenti L, Bergna A, Pelusi S, Facciotti F, Lai A, Tarkowski M, Berzuini A, Caprioli F, Santoro L, Baselli G, Della Ventura C, Erba E, Bosari S, Galli M, Zehender G, Prati D. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak. medRxiv doi.org/10.1101/2020.05.11.20098442.